News
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
The doctor tells how Ozempic might be a new boon for treating heart health problems like strokes heart attack etc ...
Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...
Semaglutide therapy in patients with obese heart failure leads to marked weight loss and notable gains in mood, function, and ...
Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results